This inventor holds 8 USPTO granted patents and 2 published patent applications. Top assignees: Rutgers, The State University of New Jersey, The State University of New York. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019-2025
Title: John A Gilleran: Innovator in Pharmaceutical Compounds
Introduction
John A Gilleran is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of pharmaceutical compounds, holding a total of 8 patents. His work focuses on therapeutic methods that have the potential to treat serious health conditions, including cancer.
Latest Patents
Gilleran's latest patents include innovative pharmaceutical compounds that provide a complex comprising Zn and a compound of formula (I), or a deuterated analog thereof. These inventions are designed to be useful for treating cancer, along with compositions and kits that incorporate such complexes. Another patent similarly involves a complex comprising Zn2+ and a compound of formula (I), emphasizing the therapeutic potential of these compounds in cancer treatment.
Career Highlights
Throughout his career, John A Gilleran has worked with prestigious institutions such as Rutgers, The State University of New Jersey, and The State University of New York. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical field.
Collaborations
Some of Gilleran's notable coworkers include Darren R Carpizo and Spencer David Kimball. Their collaborative efforts have contributed to the advancement of research and development in pharmaceutical innovations.
Conclusion
John A Gilleran's contributions to pharmaceutical compounds and therapeutic methods highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in cancer treatment and other health-related innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile